Peter Kiener

2015

In 2015, Peter Kiener earned a total compensation of $1.4M as Chief Science Officer at Sucampo Pharmaceuticals, a 23% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$267,185
Option Awards$728,151
Salary$399,188
Other$7,699
Total$1,402,222

Kiener received $728.2K in option awards, accounting for 52% of the total pay in 2015.

Kiener also received $267.2K in non-equity incentive plan, $399.2K in salary and $7.7K in other compensation.

Rankings

In 2015, Peter Kiener's compensation ranked 6,317th out of 13,638 executives tracked by ExecPay. In other words, Kiener earned more than 53.7% of executives.

ClassificationRankingPercentile
All
6,317
out of 13,638
54th
Division
Manufacturing
2,369
out of 5,190
54th
Major group
Chemicals And Allied Products
855
out of 1,854
54th
Industry group
Drugs
683
out of 1,528
55th
Industry
Pharmaceutical Preparations
532
out of 1,182
55th
Source: SEC filing on April 21, 2017.

Kiener's colleagues

We found six more compensation records of executives who worked with Peter Kiener at Sucampo Pharmaceuticals in 2015.

2015

Peter Greenleaf

Sucampo Pharmaceuticals

Chief Executive Officer

2015

Andrew Smith

Sucampo Pharmaceuticals

Chief Financial Officer

2015

Thomas Knapp

Sucampo Pharmaceuticals

Chief Legal Officer

2015

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

2015

Peter Lichtlen

Sucampo Pharmaceuticals

Chief Medical Officer

2015

Max Donley

Sucampo Pharmaceuticals

EVP, Global Human Resources, Information Technology and Strategy

In-depth

You may also like